Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3288201

CN(C)n1cc(C(=O)O)c(=O)c2cc(SCCOCCN)ccc21.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37
HSD17B10 Q99714 4/20 0.37
RAB9A P51151 2/20 0.37
TSHR P16473 2/20 0.37
LMNA P02545 4/20 0.37
HTT P42858 2/20 0.37
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
APEX1 P27695 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TOP1 P11387 1/20 0.32
POLB P06746 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
DRD3 P35462 1/20 0.32
BRD4 O60885 1/20 0.31
CYP2J2 P51589 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
PDE4A P27815 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3296590 0.93 KDM4E (0.40) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL3288208 0.88 LMNA (0.33) KDM4EALDH1A1HPGDHSD17B10RAB9A
Trifluoroacetic Acid SCHEMBL3291762 0.84 KDM4E (0.37) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL3296598 0.80 LMNA (0.35) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL3296288 0.80 BCHE (0.35) KDM4EALDH1A1HPGDHSD17B10RAB9A
Trifluoroacetic Acid SCHEMBL3980213 0.79 KDM4E (0.55) KDM4EALDH1A1HPGDHSD17B10RAB9A
Trifluoroacetic Acid SCHEMBL3819812 0.76 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10RAB9A
Trifluoroacetic Acid SCHEMBL3316561 0.76 LMNA (0.34) KDM4ELMNAHTT
SCHEMBL3293003 0.75 IDO1 (0.36) KDM4EALDH1A1HPGDHSD17B10RAB9A
Trifluoroacetic Acid SCHEMBL4142666 0.74 KDM4E (0.56) KDM4EALDH1A1HPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7718621-B2 Macrolones—amino substituted quinolones GLAXO GROUP LTD. (GB) 2010-05-18 US disclosed
US-20080090773-A1 Macrolones - Amino Substituted Quinolones GLAXO GROUP LIMITED (GB) 2008-04-17 US disclosed
EP-1824870-A1 MACROLONES - AMINO SUBSTITUTED QUINOLONES GLAXO GROUP LIMITED (GB) 2007-08-29 EP disclosed
WO-2006050942-A1 MACROLONES - AMINO SUBSTITUTED QUINOLONES GLAXO GROUP LIMITED (GB) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090773-A1 Macrolones - Amino Substituted Quinolones MRPL21, Q6ZSR9, QARS1 KDM4E 2889/4885ALDH1A1 4140/4885HPGD 2504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.